| |||||||||||
| Mice with this X-linked lox-STOP mutation of the methyl CpG binding protein 2 gene may be useful in neurological and developmental studies of Rett syndrome and its amelioration upon excision of the lox-STOP cassette. | |||||||||||
Former Names B6.129P2-Mecp2tm2Bird/J (Changed: 06-MAY-08 ) Type Mutant Stock; Targeted Mutation; Additional information on Genetically Engineered and Mutant Mice. Visit our online Nomenclature tutorial. Mating System See Colony Maintenance Species laboratory mouse Generation N6+N5 (18-DEC-08) Donating Investigator Adrian Bird, University of Edinburgh Description
These mice possess a loxP-flanked STOP cassette in intron 2 of the targeted gene on the X chromosome. Western blot and hybridization analysis confirm the absence of wildtype protein from the targeted allele (although the donating investigator reports that the targeted allele produces a "read-through" transcript which does not give rise to detectable levels of protein but makes it difficult to discriminate between the "flox-stopped" and reactivated alleles by RT-PCR). Hemizygous (Mecp2lox-Stop/y) males do not breed and develop Rett syndrome symptoms (reduced mobility, hindlimb clasping) at approximately 6 weeks of age, with death occurring at approximately 11 weeks of age. Heterozygous females are fertile until developing Rett syndrome characteristics at 4-12 months of age. This Rett syndrome-like phenotype is similar to that observed for the traditional knock-out allele (see Stock No. 003890). Cre recombinase-mediated removal of the floxed-STOP cassette restores transcription from the targeted allele and MECP2 protein activity to normal, and reverses the Rett syndrome-like neurological defects.This mutant mouse strain may be bred to a strain expressing tamoxifen inducible Cre recombinase in most tissues (see Stock No. 004682).
Mice with this X-linked lox-STOP mutation may be useful in neurological and developmental studies of Rett syndrome and its amelioration upon excision of the lox-STOP cassette.
Development
A targeting vector was designed to insert a loxP-flanked STOP-Neo cassette into intron 2 of the targeted gene. The STOP-Neo cassette is composed of a PGK-Neo cassette followed by the 3' portion of the yeast His3 gene, an SV40 polyadenylation sequence, and a false translation initiation codon followed by a 5' splice donor site. The construct was electroporated into 129P2/OlaHsd-derived E14TG2a embryonic stem (ES) cells. Correctly targeted ES cells were injected into C57BL/6 blastocysts, and chimeric offspring were bred to C57BL/6 mice. Heterozygous female mutants were bred to wild-type C57BL/6 males for 5 generations prior to arrival at The Jackson Laboratory. A SNP (single nucleotide polymorphism) panel analysis performed by The Jackson Laboratory revealed that this strain is on a mixed B6;129 genetic background background.
| Control | ||
|---|---|---|
| Wild-type from the colony | ||
| 100492 B6129PF1/J | (approximate) | |
| Considerations for Choosing Controls | ||
Strains carrying other alleles of Mecp2
003890 B6.129P2(C)-Mecp2tm1.1Bird/J 007177 B6.129P2-Mecp2tm1Bird/J 005439 B6.129S-Mecp2tm1Hzo/J 006847 B6;129P2-Mecp2tm1Bird/J View Strains carrying other alleles of Mecp2 (4 strains)
Cre-lox Systems
View Related Disease (OMIM) Terms
Related Disease (OMIM) Terms
Rett Syndrome; RTT - Models with phenotypic similarity to human disease where etiologies involve orthologs.1
1 Human genes are associated with this disease. Orthologs of those genes appear in the mouse genotype(s).
View Mammalian Phenotype Terms
Mammalian Phenotype Terms
assigned by genotype
The following phenotype information may relate to a genetic background differing from this JAX® Mice strain.
Mecp2tm2Bird/Mecp2+
involves: 129P2/OlaHsd * C57BL/6
- behavior/neurological phenotype
- abnormal behavior (MGI Ref ID J:118365)
- at 4 to 12 months of age, mice exhibit a progressive development of RTT-like symptoms (inertia, gait, hindlimb clasping, tremor, irregular breathing and poor general condition)
- limb grasping (MGI Ref ID J:118365)
- at 4 to 12 months of age
- tremors (MGI Ref ID J:118365)
- at 4 to 12 months of age
- growth/size phenotype
- obese (MGI Ref ID J:118365)
- mice exhibit excess weight gain
- nervous system phenotype
- reduced long term potentiation (MGI Ref ID J:118365)
- mice develop a reduction in long term potentiation
- respiratory system phenotype
- abnormal breathing (MGI Ref ID J:118365)
- at 4 to 12 months of age
Mecp2tm2Bird/Y
involves: 129P2/OlaHsd * C57BL/6
- life span-post-weaning/aging
- premature death (MGI Ref ID J:118365)
- male mice survive on average 11 weeks from birth
- behavior/neurological phenotype
- abnormal behavior (MGI Ref ID J:118365)
- during the last 4 weeks of life, mice exhibit a progressive development of RTT-like symptoms (inertia, gait, hindlimb clasping, tremor, irregular breathing and poor general condition)
- at 12 weeks mice display low stance, inertia, tremor, arrhythmic breathing, splayed himdlimb and moderate hindlimb clasping
- limb grasping (MGI Ref ID J:118365)
- at 12 weeks, mice display moderate hindlimb clasping
- tremors (MGI Ref ID J:118365)
- at 12 weeks
- respiratory system phenotype
- abnormal breathing (MGI Ref ID J:118365)
- at 12 weeks
The following phenotype relates to a compound genotype created using this strain.
Contact JAX® Services jaxservices@jax.org for customized breeding options.Mecp2tm2Bird/Mecp2+ Tg(CAG-cre/Esr1)5Amc/?
involves: 129P2/OlaHsd * C57BL/6 * CBA (conditional)
- behavior/neurological phenotype
- abnormal behavior (MGI Ref ID J:118365)
- at 4 to 12 months of age, mice exhibit a progressive development of RTT-like symptoms (inertia, gait, hindlimb clasping, tremor, irregular breathing and poor general condition)
- however, tamoxifen treatment after the onset of symptoms reverses symptom progression
- limb grasping (MGI Ref ID J:118365)
- at 4 to 12 months of age
- however, tamoxifen treatment after the onset of symptoms reverses symptom progression
- tremors (MGI Ref ID J:118365)
- at 4 to 12 months of age
- however, tamoxifen treatment after the onset of symptoms reverses symptom progression
- nervous system phenotype
- reduced long term potentiation (MGI Ref ID J:118365)
- mice develop a reduction in long term potentiation
- however, treatment with tamoxifen returns long term potentiation to normal levels
- respiratory system phenotype
- abnormal breathing (MGI Ref ID J:118365)
- at 4 to 12 months of age
- however, tamoxifen treatment after the onset of symptoms reverses symptom progression
- growth/size phenotype
- obese (MGI Ref ID J:118365)
- mice exhibit excess weight gain
- however, tamoxifen treatment after the onset of symptoms reverses weight gain
Mecp2tm2Bird/Y Tg(CAG-cre/Esr1)5Amc/0
involves: 129P2/OlaHsd * C57BL/6 * CBA (conditional)
- life span-post-weaning/aging
- premature death (MGI Ref ID J:118365)
- 9 of 17 mice treated with tamoxifen at 3 to 4 weeks of age die soon after treatment
- however, tamoxifen-tocixity is not responsible for observed deaths, 8 of 17 mice treated with tamoxifen at 3 to 4 weeks of age have a normal life span, and mice treated with tamoxifen from week 12 to 17 exhibit normal lethality
- behavior/neurological phenotype
- *normal* behavior/neurological phenotype (MGI Ref ID J:118365)
- the surviving 8 of 17 mice treated with tamoxifen at 3 to 4 weeks of age exhibit normal behavior/neurological phenotypes
- abnormal behavior (MGI Ref ID J:118365)
- at 12 weeks mice display low stance, inertia, tremor, arrhythmic breathing, splayed himdlimb and moderate hindlimb clasping
- during the last 4 weeks of life, mice exhibit a progressive development of RTT-like symptoms (inertia, gait, hindlimb clasping, tremor, irregular breathing and poor general condition)
- mice treated with tamoxifen at 12 to 17 weeks of age exhibit only mild RTT-like symptoms
- limb grasping (MGI Ref ID J:118365)
- at 12 weeks, mice display moderate hindlimb clasping
- mice treated with tamoxifen at 12 to 17 weeks of age exhibit only mild RTT-like symptoms
- tremors (MGI Ref ID J:118365)
- at 12 weeks
- mice treated with tamoxifen at 12 to 17 weeks of age exhibit only mild RTT-like symptoms
- respiratory system phenotype
- abnormal breathing (MGI Ref ID J:118365)
- at 12 weeks
- mice treated with tamoxifen at 12 to 17 weeks of age exhibit only mild RTT-like symptoms
| Allele Symbol | Mecp2tm2Bird | ||
|---|---|---|---|
| Allele Name | targeted mutation 2, Adrian Bird | ||
| Allele Type | Targeted (Floxed/Frt) | ||
| Common Name(s) | Mecp2lox-stop; | ||
| Mutation Made By | Adrian Bird, University of Edinburgh | ||
| Strain of Origin | 129P2/OlaHsd | ||
| ES Cell Line Name | E14TG2a | ||
| ES Cell Line Strain | 129P2/OlaHsd | ||
| Gene Symbol and Name | Mecp2, methyl CpG binding protein 2 | ||
| Chromosome | X | ||
| Gene Common Name(s) | 1500041B07Rik; AUTSX3; BB130002; D630021H01Rik; DKFZp686A24160; MRX16; MRX79; MRXS13; MRXSL; Mbd5; PPMX; RIKEN cDNA 1500041B07 gene; RIKEN cDNA D630021H01 gene; RTS; RTT; WBP10; expressed sequence BB130002; | ||
| Molecular Note | Cre recombinase-reversible gene inactivation was accomplished by insertion into intron 2 of a 3.1-kb DNA fragment containing a loxP-flanked "neostop" cassette, which comprises a neomycin resistance cassette followed by a transcriptional/translational "stop" cassette composed of 550 bp of 3' sequence from the Saccharomyces cerevisiae His3 gene, an SV40 polyadenylation sequence, and a synthetic sequence containing a false translation initiation codon (ATG) immediately followed by a consensus splice donor sequence. Despite the production of a read-through transcript, no protein product was detected by western blot or immunofluorescence analysis of brains of mutant mice. [MGI Ref ID J:111323] [MGI Ref ID J:118365] [MGI Ref ID J:75205] | ||
Genotyping Protocols
Mecp2tm2Bird, STD PCR, vers. 1
Mept2tm2bird, MCA, vers. 1
Helpful Links
Genotyping resources and troubleshooting
Guy J; Gan J; Selfridge J; Cobb S; Bird A. 2007. Reversal of neurological defects in a mouse model of Rett syndrome. Science 315(5815):1143-7. [PubMed: 17289941] [MGI Ref ID J:118365]
Dragatsis I; Zeitlin S. 2001. A method for the generation of conditional gene repair mutations in mice. Nucleic Acids Res 29(3):E10. [PubMed: 11160912] [MGI Ref ID J:111323]
Mecp2tm2Bird relatedDragatsis I; Zeitlin S. 2001. A method for the generation of conditional gene repair mutations in mice. Nucleic Acids Res 29(3):E10. [PubMed: 11160912] [MGI Ref ID J:111323]
Lakso M; Sauer B; Mosinger B Jr; Lee EJ; Manning RW; Yu SH; Mulder KL; Westphal H. 1992. Targeted oncogene activation by site-specific recombination in transgenic mice. Proc Natl Acad Sci U S A 89(14):6232-6. [PubMed: 1631115] [MGI Ref ID J:75205]
Animal Health Reports
Room Number AX11
Colony Maintenance
Breeding & Husbandry When maintaining a live colony, females heterozygous for this X-linked mutation can be bred with wildtype male siblings. The donating investigator recommends replacing heterozygous female breeders when Rett syndrome symptoms appear or when females fail to produce or care for regular litters (may be as early as 4-6 months). The donating investigator also reports that breeding performance may be improved if mice are maintained on a mixed C57BL/6;BALB/c background. Mating System See above Diet Information LabDiet® 5K52/5K67
| Pricing for USA, Canada and Mexico shipping destinations |
|
Weeks of Age Price (US dollars $) Gender Genotypes Provided Individual Mouse $243.50 Male Hemizygous for Mecp2tm2Bird $243.50 Female Heterozygous for Mecp2tm2Bird
Pairs /Price (US dollars $) Pair Genotype $297.85 Heterozygous for Mecp2tm2Bird x Wild-type for Mecp2tm2Bird
| Pricing for International shipping destinations |
|
Weeks of Age Price (US dollars $) Gender Genotypes Provided Individual Mouse $316.60 Male Hemizygous for Mecp2tm2Bird $316.60 Female Heterozygous for Mecp2tm2Bird
Pairs /Price (US dollars $) Pair Genotype $387.30 Heterozygous for Mecp2tm2Bird x Wild-type for Mecp2tm2Bird
| Standard Supply | Repository-Live. A collection of over 1000 strains maintained as live colonies. Individual colonies are sized to meet current customer demand. Delivery for orders of 10 mice or less ranges on average from one to eight weeks; mice are generally shipped between four to six weeks of age with a maximum shipping age of approximately nine weeks. Colony sizes do not generally support stringent age specifications for large volumes of mice; however custom orders and larger quantities of mice are easily arranged. Estimated ship dates for all orders provided within two business days following order placement. |
|---|---|
| Supply Notes |
|
| Control | ||
|---|---|---|
| Wild-type from the colony | ||
| 100492 B6129PF1/J | (approximate) | |
| Considerations for Choosing Controls | ||
| USA, Canada and Mexico - Control Pricing Information for Genetically Engineered Mutant Strains. | ||
| International - Control Pricing Information for Genetically Engineered Mutant Strains. | ||
Purchasing Information
JAX® Mice Orders
Surgical Services
Contact Information
Orders & Technical Support
Tel: 1-800-422-6423 or 1-207-288-5845
Fax: 1-207-288-6150
Technical Support Email Form
| phone: | 207-288-6470 |
| fax: | 207-288-6655 |
MICE, PRODUCTS AND SERVICES ARE PROVIDED “AS IS”. JACKSON EXTENDS NO WARRANTIES OF ANY KIND, EITHER EXPRESS, IMPLIED, OR STATUTORY, WITH RESPECT TO MICE, PRODUCTS OR SERVICES, INCLUDING ANY IMPLIED WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, OR ANY WARRANTY OF NON-INFRINGEMENT OF ANY PATENT, TRADEMARK, OR OTHER INTELLECTUAL PROPERTY RIGHTS.
In case of dissatisfaction for a valid reason and claimed in writing by a purchaser within ninety (90) days of receipt of mice, products or services, JACKSON will, at its option, provide credit or replacement for the mice or product received or the services provided.
In no event shall JACKSON, its trustees, directors, officers, employees, and affiliates be liable for any causes of action or damages, including any direct, indirect, special, or consequential damages, arising out of the provision of MICE, PRODUCTS or services, including economic damage or injury to property and lost profits, and including any damage arising from acts or negligence on the part of JACKSON, its agents or employees. In purchasing or receiving MICE, PRODUCTS or services from JACKSON, purchaser or recipient, or any party claiming by or through them, expressly releases and discharges JACKSON from all such causes of action or damages, and further agrees to defend and indemnify JACKSON from any costs or damages arising out of any third party claims.
MICE and PRODUCTS are to be used in a safe manner and in accordance with all applicable governmental rules and regulations.
The foregoing represents the General Terms and Conditions applicable to JACKSON’s MICE, PRODUCTS or services. In addition, special terms and conditions of sale of certain MICE, PRODUCTS or services may be set forth separately in JACKSON web pages, catalogs, price lists, contracts, and/or other documents, and these special terms and conditions shall also govern the sale of these MICE, PRODUCTS and services by JACKSON, and by its licensees and distributors.
Acceptance of delivery of MICE, PRODUCTS or services shall be deemed agreement to these terms and conditions. No purchase order or other document transmitted by purchaser or recipient that may modify the terms and conditions hereof, shall be in any way binding on JACKSON, and instead the terms and conditions set forth herein, including any special terms and conditions set forth separately, shall govern the sale of MICE, PRODUCTS or services by JACKSON.